🇺🇸 FDA
Patent

US 11524939

Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

granted A61KA61K9/0053A61K9/145

Quick answer

US patent 11524939 (Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid) held by Akebia Therapeutics, Inc. expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Akebia Therapeutics, Inc.
Grant date
Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K9/0053, A61K9/145